BRIEF published on 07/16/2025 at 08:05, 1 year 1 month ago GeNeuro SA announces the liquidation of its French subsidiary Restructuring Liquidation GeNeuro Subsidiary Neurodegenerative
PRESS RELEASE published on 07/16/2025 at 08:00, 1 year 1 month ago Inside Information / Other news releases GeNeuro SA announces the liquidation of its French subsidiary GeNeuro Innovation SAS, part of the restructuring process. Court appointed liquidator SELARL MJ-Synergie Liquidation Restructuring Process GeNeuro SA GeNeuro Innovation SAS SELARL MJ-Synergie
BRIEF published on 06/30/2025 at 19:42, 1 year 2 months ago GeNeuro's Shareholders Approve All Resolutions at Extraordinary General Meeting Shareholder Approval Restructuring Extraordinary General Meeting GeNeuro Asset Monetization
PRESS RELEASE published on 06/30/2025 at 19:37, 1 year 2 months ago Inside Information / Other news releases GeNeuro announces approval of all resolutions proposed at Extraordinary General Meeting with 69.1% share capital representation. Jesús Martin-Garcia named Executive Chairman Shareholders EGM Resolutions GeNeuro Jesús Martin-Garcia
BRIEF published on 06/12/2025 at 22:47, 1 year 2 months ago GeNeuro SA: Judicial recovery for its French subsidiary Restructuring GeNeuro SA Judicial Recovery French Subsidiary Judicial Administrator
PRESS RELEASE published on 06/12/2025 at 22:42, 1 year 2 months ago Inside Information / Other news releases GeNeuro SA's French subsidiary GeNeuro Innovation SAS enters receivership proceedings amidst parent company's debt-restructuring efforts Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Receivership Proceedings
BRIEF published on 12/13/2024 at 12:02, 1 year 8 months ago Citigroup reduces its stake in GENEURO SA Euronext Paris Sale Of Shares Threshold Crossing GeNeuro SA Citigroup
BRIEF published on 12/06/2024 at 18:35, 1 year 8 months ago GeNeuro's New Precision Medicine for ALS Unveiled Precision Medicine GeNeuro ALS Treatment GNK-301 HERV-K ENV
PRESS RELEASE published on 12/06/2024 at 18:30, 1 year 8 months ago Inside Information / Other news releases GeNeuro presents groundbreaking findings on precision medicine for ALS patients with GNK-301 at the 35th International Symposium on ALS/MND. Research highlights potential of targeting HERV-K ENV to transform ALS treatment Precision Medicine ALS GeNeuro GNK-301 HERV-K ENV
BRIEF published on 11/06/2024 at 09:48, 1 year 9 months ago Crossing of thresholds by Invus Public Equities in GENEURO SA Euronext Paris Capital Increase Crossing Thresholds GeNeuro SA Invus Public Equities
Published on 09/05/2026 at 04:05, 1 day 5 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 1 day 9 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 1 day 10 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 1 day 10 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 1 day 18 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/06/2026 at 06:00, 3 hours 24 minutes ago CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026
Published on 09/06/2026 at 05:15, 4 hours 10 minutes ago Experience AI Companion in Everyday Life at Hisense IFA 2026
Published on 09/05/2026 at 22:20, 11 hours 5 minutes ago PITAKA Marks Its Next Chapter in Berlin With "Signals in the Wind," Unveiling New iPhone 18 Accessories
Published on 09/05/2026 at 19:35, 13 hours 50 minutes ago ToolDance Unveils X1 Smart Desktop CNC Mill at IFA 2026
Published on 09/05/2026 at 14:00, 19 hours 25 minutes ago Global investment boom could create USD 200 billion commercial insurance opportunity amid rising accumulation risks, finds Swiss Re Institute
Published on 09/04/2026 at 18:57, 1 day 14 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 1 day 15 hours ago Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 16:00, 1 day 17 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 1 day 17 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
